Delivery Order SPE2DB25D3006-SPE2DB25FXKLR
Award Date 9/16/25
Potential Completion Date 9/17/25
Potential Value $25K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $47,526.27 to AmerisourceBergen Drug Corp for the supply of Deferasirox 360 mg tablets (30-count units). This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by September 5, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $10,368 delivery order to AmerisourceBergen Drug Corp for Deferasirox 360 mg granule packets (30 count) on September 10, 2025, with a completion date of September 11, 2025. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. The award was competitively awarded without set-aside designation, reflecting the...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DEFERASIROX 360 MG TABLET 30S, a medical product, with a ceiling value of $54,663.84 and a performance period through May 20, 2025. The contract is a firm-fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the for-profit Amerisourcebergen Corporation. The contract is for the delivery of Deferasirox 500 mg tablets for suspension, with a completion date of February 1, 2024 and a potential value of $2,946.36. The contract is a firm fixed price delivery order and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and serves as a major...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DEFERASIROX 500 MG TB FOR SUSP 30S, a pharmaceutical product, with a ceiling value of $38,879.80 and a period of performance through May 12, 2023. The contract is a Firm Fixed Price, Delivery Order type with no set-aside designation, indicating open competition. AmerisourceBergen...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide DEFERASIROX 360 MG TABLET 30S. The firm fixed price contract has a potential value of $13,105.98 and a performance completion date of December 29, 2023. No set-aside designation was used. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to supply pharmaceuticals, medical...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp in the amount of $25,052.94 for the supply of Deferiprone 1,000 mg tablets. The contract has a firm fixed price and provides for the delivery of this pharmaceutical product through June 26, 2024. Amerisourcebergen, a major pharmaceutical distribution company, supports the DLA's mission to provide logistics, acquisition, and technical services to the U.S. Armed Forces and other government...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,146,414 units of 500 mg deferiprone tablets, valued at $4,006.27. The contract has an ultimate completion date of January 30, 2025 and is a firm fixed-price delivery order. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,535.42 contract is for the delivery of Exjade 125 mg tablets and has an ultimate completion date of August 3, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical to provide a comprehensive range of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,062.11 to AmerisourceBergen Drug Corp for the supply of JADENU 360 mg tablets (30-count units). This firm fixed-price delivery order, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery at its corporate office...